Effekten af palivizumab administreret for anden gang til patienter i løbet af den påfølgende RSV sæson er ikke blevet undersøgt formelt i et studie gennemført med dette formål.
The efficacy of palivizumab when administered to patients as a second course of treatment during an ensuing RSV season has not been formally investigated in a study performed with this objective.